Apyx Medical (APYX) Gains from Sales and Divestitures (2011 - 2025)

Apyx Medical (APYX) reported Gains from Sales and Divestitures of $1.5 million for Q4 2025, up 37.31% on a YoY basis from $1.1 million in Q4 2024, and up 37.31% quarter-over-quarter from $1.1 million in Q4 2024.

Apyx Medical (APYX) Gains from Sales and Divestitures (2011 - 2025) Analysis & Trends

Apyx Medical has reported Gains from Sales and Divestitures for 5 years, with the latest figure at $1.5 million in Q4 2025.

  • For the quarter ending Q4 2025, Gains from Sales and Divestitures rose 37.31% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2025 stood at $1.5 million (up 37.31% YoY), and the FY2025 full-year result was $1.5 million, up 37.31% from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 stood at $1.5 million, up from $1.1 million in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $1.5 million in Q4 2025, with the low at $1.1 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Apyx Medical 205.37 Mn 174.49 Mn 7.93 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.52 Mn
Dec 31, 2025 1.52 Mn
Dec 31, 2024 1.11 Mn
Dec 31, 2024 1.11 Mn
Mar 31, 2013 1,000.00
Mar 31, 2013 1,000.00
Sep 30, 2012 46,000.00
Sep 30, 2012 46,000.00
Jun 30, 2012 -5,000.00
Jun 30, 2012 -5,000.00
Dec 31, 2011 1,000.00
Dec 31, 2011 1,000.00